BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $522,322 | -19.3% | 13,840 | -2.6% | 0.01% | -14.3% |
| Q2 2023 | $647,636 | +106069.8% | 14,215 | -5.5% | 0.01% | 0.0% |
| Q1 2023 | $610 | -63.5% | 15,044 | -54.1% | 0.01% | -63.2% |
| Q4 2022 | $1,669 | -100.0% | 32,761 | -48.4% | 0.02% | -53.7% |
| Q3 2022 | $3,422,000 | -32.5% | 63,450 | -19.8% | 0.04% | -28.1% |
| Q2 2022 | $5,070,000 | -22.0% | 79,114 | -5.4% | 0.06% | -8.1% |
| Q1 2022 | $6,498,000 | -20.0% | 83,598 | -11.5% | 0.06% | -17.3% |
| Q4 2021 | $8,121,000 | -52.5% | 94,487 | -55.6% | 0.08% | -8.5% |
| Q3 2021 | $17,080,000 | +21.3% | 212,886 | +21.4% | 0.08% | -40.1% |
| Q2 2021 | $14,080,000 | -22.0% | 175,305 | -18.1% | 0.14% | -23.0% |
| Q1 2021 | $18,041,000 | -48.7% | 213,924 | -51.2% | 0.18% | -54.5% |
| Q4 2020 | $35,141,000 | -0.8% | 438,587 | -0.6% | 0.39% | -18.7% |
| Q3 2020 | $35,425,000 | -11.1% | 441,298 | -4.6% | 0.48% | -28.2% |
| Q2 2020 | $39,846,000 | +3.8% | 462,765 | -2.2% | 0.67% | -14.1% |
| Q1 2020 | $38,385,000 | +12.7% | 473,383 | +16.2% | 0.78% | +47.7% |
| Q4 2019 | $34,045,000 | -4.9% | 407,276 | -0.6% | 0.53% | -5.0% |
| Q3 2019 | $35,784,000 | -7.3% | 409,584 | -13.1% | 0.56% | -4.6% |
| Q2 2019 | $38,598,000 | -6.0% | 471,211 | -6.7% | 0.58% | -8.6% |
| Q1 2019 | $41,069,000 | +14.5% | 505,290 | -7.3% | 0.64% | +3.2% |
| Q4 2018 | $35,866,000 | -5.9% | 544,905 | +10.2% | 0.62% | +10.2% |
| Q3 2018 | $38,135,000 | +1.4% | 494,677 | -2.9% | 0.56% | -2.1% |
| Q2 2018 | $37,622,000 | +45.2% | 509,513 | +27.9% | 0.57% | -4.5% |
| Q1 2018 | $25,917,000 | -4.9% | 398,484 | -5.5% | 0.60% | 0.0% |
| Q4 2017 | $27,247,000 | +5.4% | 421,520 | +2.3% | 0.60% | -0.2% |
| Q3 2017 | $25,856,000 | +220.2% | 412,054 | +209.0% | 0.60% | +216.3% |
| Q2 2017 | $8,074,000 | +13.5% | 133,369 | -2.7% | 0.19% | +10.5% |
| Q1 2017 | $7,111,000 | +6.7% | 137,121 | -8.8% | 0.17% | +3.0% |
| Q4 2016 | $6,664,000 | -11.1% | 150,290 | -4.6% | 0.17% | -13.0% |
| Q3 2016 | $7,496,000 | -17.9% | 157,479 | -22.0% | 0.19% | -20.3% |
| Q2 2016 | $9,132,000 | +5.4% | 201,943 | -4.3% | 0.24% | +12.1% |
| Q1 2016 | $8,668,000 | +6.0% | 211,002 | -1.5% | 0.22% | +9.7% |
| Q4 2015 | $8,174,000 | +14.6% | 214,256 | -1.3% | 0.20% | +12.6% |
| Q3 2015 | $7,133,000 | -60.9% | 217,131 | -16.7% | 0.17% | -57.4% |
| Q2 2015 | $18,236,000 | -2.3% | 260,768 | -4.3% | 0.41% | -2.9% |
| Q1 2015 | $18,657,000 | -43.4% | 272,358 | -39.4% | 0.42% | -43.5% |
| Q4 2014 | $32,964,000 | -2.8% | 449,779 | -4.8% | 0.74% | -5.1% |
| Q3 2014 | $33,908,000 | -0.9% | 472,453 | -0.2% | 0.78% | -3.8% |
| Q2 2014 | $34,225,000 | -52.2% | 473,369 | -51.3% | 0.82% | -4.7% |
| Q1 2014 | $71,558,000 | +1.8% | 972,516 | -3.7% | 0.86% | +3.6% |
| Q4 2013 | $70,270,000 | +118.9% | 1,010,362 | +106.8% | 0.82% | +4.0% |
| Q3 2013 | $32,099,000 | -3.7% | 488,646 | +1.6% | 0.79% | -9.8% |
| Q2 2013 | $33,318,000 | -6.2% | 480,983 | -1.6% | 0.88% | -6.9% |
| Q1 2013 | $35,513,000 | – | 488,890 | – | 0.94% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |